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Abstract
Granulocyte-Colony Stimulating Factor (G-CSF) is an endogenous hematopoietic growth factor known for its role in the
proliferation and differentiation of cells of the myeloic lineage. Only recently its significance in the CNS has been uncovered.
G-CSF attenuates apoptosis and controls proliferation and differentiation of neural stem cells. G-CSF activates upstream
kinases of the cAMP response element binding protein (CREB), which is thought to facilitate the survival of neuronal
precursors and to recruit new neurons into the dentate gyrus. CREB is also essential for spatial long-term memory formation.
To assess the role and the potential of this factor on learning and memory-formation we systemically administered G-CSF in
rats engaged in spatial learning in an eight-arm radial maze. G-CSF significantly improved spatial learning and increased in
combination with cognitive training the survival of newborn neurons in the hippocampus as measured by
bromodeoxyuridine and doublecortin immunohistochemistry. Additionally, G-CSF improved re-acquisition of spatial
information after 26 days. These findings support the hypothesis that G-CSF can enhance learning and memory formation.
Due to its easy applicability and its history as a well-tolerated hematological drug, the use of G-CSF opens up new
neurological treatment opportunities in conditions where learning and memory-formation deficits occur.
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Introduction
Granulocyte-colony stimulating factor (G-CSF), a hematopoi-
etic growth factor known for its prominent role in proliferation and
differentiation of hematopoietic cells [1,2], is one of a surprising
variety of peripheral circulating peptides that have the ability to
alter CNS functions and structure. Several of these peptides,
including G-CSF, have specific receptors in the brain and, most
importantly, are even produced in the brain [3]. Recent studies
showed that peripheral peptides like erythropoietin [4], Insulin-
like growth factor 1 [5,6], Glucagon-like peptide-1 [7] and ghrelin
[8] exert action in the CNS. Some of these factors have been
shown to induce neuroplasticity and specifically in the hippocam-
pus, changes in neuronal complexity, neurogenesis and LTP.
The G-CSF ligand and receptor show a broad, predominantly
neuronal expression throughout the rat brain, with particularly
high expression in the CA3 region of the hippocampal formation
and the subgranular zone and hilus of the dentate gyrus [9]. We
recently showed that G-CSF attenuates apoptosis and controls
proliferation and differentiation of neural stem cells, generally
fulfilling the criteria of a classic neurotrophic factor [9]. Moreover,
it has been demonstrated that G-CSF after binding to its receptor
evokes the MAP kinase pathway by activating ERK 1,2 and 5,
upstream kinases of CREB, shown to be essential for spatial long
term memory formation [10,11]. CREB activation is furthermore
thought to facilitate the survival of neuronal precursors and to
recruit new neurons into the dentate gyrus [12].
TheexpressionpatternofG-CSFligandanditsreceptorcombined
with its strong trophic activity and signalling prerequisitions indicate a
prominent role in hippocampal function for G-CSF. We therefore
administered G-CSF to rats before and during spatial learning and
assessed memory formation and hippocampal neurogenesis.
Materials and Methods
Ethics Statement
All behavioral testing was performed during the rats’ light cycle
between 8:00 a.m. and 1:00 p.m. All experiments were done in
accordance with the European Communities Council Directive of
24 November 1986 (86/609/EEC).
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A total of 60 male Wistar rats (Charles River, Sulzfeld,
Germany), weighing 180–200 g upon arrival were used in the
experiments. They were housed in groups of two animals in
Macrolon cages. All rats were kept under controlled environmen-
tal conditions (ambient temperature 22uC, 12-h light/dark cycle,
lights on at 7:00 a.m.). Standard laboratory chow (Altromin1324,
Lage, Germany) was restricted to 16 g per animal per 24 h. This
controlled feeding schedule was continued throughout the whole
testing period, keeping the animals’ body weight on approximately
85% of the free feeding weight. Tap water was allowed ad libitum.
The behavioral testing began two weeks after the animals’ arrival.
Rats were handled daily by the experimenter during this period.
Apparatus and training
The radial eight-arm maze was constructed of gray plastic with
a central platform (35 cm in diameter) and eight arms (each
57.5 cm long and 13 cm wide provided with a 2.0 cm rim)
projecting radially from this platform with adjacent arms
separated by 45u. Each arm was surrounded by a transparent
Plexiglas wall (30 cm high). The maze was elevated 35.0 cm off
the floor. A nontransparent food cup (0.5 cm high, 8.5 cm in
diameter) which concealed the food reward (Bioserv dustless
precision pellets 45 mg, Frenchtown, USA) from view was
positioned at the distal end of each arm. The maze was set in
an experimental room with several external visual cues. The
experimenter monitored the movements of the rats via a video
camera mounted above the maze and a TV-screen outside the
rats’ range of vision. On the first day each rat was allowed to
explore the maze. Food pellets were scattered throughout the
maze and placed in the food cups. The rat was removed from the
maze when all pellets were consumed. The training procedure
started on the next day with the food wells of four arms baited (one
pellet each) and four arms unbaited. For each rat, the four baited
arms were randomly chosen with the restriction that no more than
two adjacent arms were baited. The spatial location of the baited
arms was constant with respect to extra-maze cues. Each rat was
trained with two trials a day. A trial began with the experimenter
placing a rat on the central platform of the maze with orientation
randomly varying from trial to trial and ended when all reward
pellets had been collected. Time between trials for each rat was
90 min. Performance was indexed by the number of errors per
trial. Two types of errors were identified: The first entry into an
unbaited arm was classified as a reference memory error, which
implies that the maximum number of reference memory errors per
trial is four. Re-entries into arms visited before were classified as
working memory errors. Additionally, we monitored the duration
of each trial. Between trials the maze was wiped off with a mild
disinfectant. The animals were retested after 26 days for a further
three days (2 trials each day). The spatial location of the baited
arms for each remained unchanged. To examine a possible
treatment effect on locomotor function we divided the total
duration of each trial by the amount of arm entries. This value is
used as an indicator for locomotor function.
Experimental design
The design of the present study is illustrated in Figure 1. The
experiments were performed on a total number of 60 animals
subdivided into 6 different treatment groups.
The animals of group 1 (n=10) and 2 (n=10) received daily
injections of G-CSF (group 1) (20 mg/kg, s.c.) or saline (group 2)
1 hour prior to the maze training throughout an 11-day training
period in the radial maze. They were subsequently anesthetized
and transcardially perfused with 200 ml saline (d12).
The animals of group 3 (n=10) and 4 (n=10) also received
daily injections of G-CSF (group 3) or saline (group 4) 1 hour prior
to the maze training throughout the 11-day training period in the
radial maze. The animals were retested after 26 days for further
Figure 1. Experimental design showing the different interventions and points of measurement.
doi:10.1371/journal.pone.0005303.g001
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transcardially perfused.
Animals of group 5 (n=10) and 6 (n=10) were treated daily
with G-CSF (group 5) or saline (group 6) over 11 days. Instead of
being trained in the radial arm maze, the animals were simply
placed on the apparatus every day and were given four food
pellets. On day 40 the animals were anesthetized and perfused.
For the purpose of labeling dividing cells each rat received a
daily bromodeoxyuridine (BrdU) injection (50 mg/kg/d, i.p.)
throughout the 11 day-acquisition-period, 16 hours prior to G-
CSF/saline injection.
Tissue processing
Animals were deeply anaesthetized using a mixture of ketamine
(20.38 mg/mL) and xylazine (5.38 mg/mL). Transcardiac perfu-
sion was performed with 0.9% NaCl solution. The brain was
removed and postfixed in 4% paraformaldehyde solution for 4
days at 4uC. The tissue was then cryoprotected by 24 h immersion
in 30% sucrose-PBS solution. 40-mm sagittal sections were cut on
dry ice using a sliding microtome.
Immunohistostaining
All experiments were done in a fully randomized and blinded
fashion. We used two different time points for the detection of
neurogenesis in order to differentiate between generation and survival
of newborn neurons in the dentate gyrus. For Group 1 (n=10) and 2
(n=10) Doublecortin (DCX) was used to determine the amount of
newborn neurons within the dentate gyrus after the 11 day-
acquisition-period. For Group 3 (n=10), 4 (n=10), 5 (n=10) and
6 (n=10) BrdU labeling was used for the detection of neurogenesis.
Free-floating sections were treated with 0.6% H2O2 in Tris-
buffered saline (TBS; 0.15 m NaCl, 0.1 m Tris-HCl, pH 7.5) for
30 min. Following extensive washes in TBS, sections were blocked
with a solution containing TBS, 0.1% Triton-X100 and 3% normal
donkey serum solution for 30 min. The same solution was used
during the incubation with antibodies. Primary antibodies were
applied overnight at 4uC. For epifluorescence immunodetection,
sections were washed extensively and incubated with fluorochrome-
conjugated species-specific secondary antibodies. Sections were
placed on Superfrost Plus slides (Menzel-Gla ¨ser, Germany) and
mounted in Prolong Antifade kit (Molecular Probes).
The following antibodies were used: Rat anti-BrdU (1:500,
Accurrate), mouse anti-NeuN (1:500, Chemicon), goat anti-DCX
C-18 (1:500, Santa Cruz).
Counting procedures
To determine the number of DCX- or BrdU-positive cells in the
hippocampus, every 12th section (480-mm intervals) of one
cerebral hemisphere was selected from each animal and processed
for immunohistochemistry. All DCX- and BrdU-positive cells in
the granule cell layer of the hippocampal dentate gyrus were
counted on eight sections per animal. The amount of cells counted
was then extrapolated to receive an approximated value for the
whole brain. For co-labeling with neuronal marker NeuN to
estimate the percentage of neurons among the newly generated
cells, 50 randomly selected BrdU-positive cells per animal were
analyzed under the confocal microscope. Multiplying the total
number of BrdU-positive cells with the percentage of NeuN/BrdU
double-positive cells yielded the number of new neurons in the
dentate gyrus.
To determine the number of BrdU-positive cells in the olfactory
bulb a systematic, random counting procedure, similar to the
optical dissector, was used as described by Williams & Rakic (1988)
[13]. The volume of each structure was determined by tracing the
areas using a semiautomatic stereology system (StereoInvestigator,
MicroBrightField, Colchester, VT, USA).
Statistical analysis
All analyses were performed with the statistical software SPSS
(version 13.00 for Windows). One-way analysis of variance
(ANOVA) was used to compare data between groups. Two-way
ANOVA was used when data of different groups were repeatedly
collected over time or under different treatment conditions (e.g. G-
CSF/vehicle). For the statistical analysis of radial eight-arm maze
performance, two-way repeated measures ANOVA was calculated
over 22 trials (acquisition period) and 6 trials (reacquisition period).
Post hoc comparisons were made using Fisher protected least
significant difference test. A Student’s t-test was calculated for the
statistical analysis of DCX positive cells. All tests performed were
two-tailed and a value of p,0.05 was considered to represent a
significant difference.
Results
Radial maze spatial memory task
We examined the effects of G-CSF treatment on reference and
working memory during spatial learning. G-CSF treatment
significantly reduced the number of reference memory errors
(Figure 2A). An ANOVA with repeated measures revealed
significant effects of group (F(1,38): 6.552; p=0.015) and trial
(F(1,38): 256.654; p,0.001), but not group by trial interaction
(p=0.325). This effect continued during the reacquisition period
26 days later (ANOVA group (F(1,18): 6,586; p=0.019), trial
(F(1,18): 11.129; p=0.004), group by trial interaction (p=0.525)).
In order to demonstrate that the differences in the reacquisition
trials are not caused by a better acquisition of the task in the first
trials we calculated a covariance analysis with the last trial of the
acquisition period as a covariate. This analysis revealed a
statistically significant group effect between the treatment groups
(F(1,17): 5.826; p=0.027). In contrast to the improvement in the
formation of reference memory, G-CSF did not improve working
memory to a significant level in the initial acquisition phase
(Figure 2A) (ANOVA group p=0.061, trial (F(1,38): 95,019;
p,0.001), group by trial interaction (p=0.952)). However, in the
reacquisition phase 26 days later G-CSF treated animals made
significantly less working memory errors (ANOVA group F(1,18):
5.333 (p=0.033), trial (F(1,18): 11.155; p=0.004) group by trial
interaction (F(1,18): 5.186, p=0.035)).
We also examined the effects of G-CSF treatment on locomotor
function and appetite, both of which affect performance in the
radial arm maze test. There were no differences in locomotor
activity and body weight between the G-CSF and saline-treated
rats (p.0.05, Student’s t test, data not shown). Thus, it is unlikely
that the differences in maze performance in rats are a secondary
effect of motor dysfunction or an altered motivational state.
Neurogenesis detection
Using DCX immunohistochemistry, we determined the amount
of newborn cells after the 11- day-(training)-period. There was no
significant treatment effect on the amount of DCX-positive cells
(Student’s t test, p=0.277; G-CSF-treated animals: 930.6+/271.6
S.E.M.; vehicle-treated animals: 829+/255.6).
To assess whether G-CSF treatment led to an increased survival
of adult-born neurons generated during the 11-day training
period, we counted BrdU/NeuN double-positive cells in the
dentate gyrus after the reacquisition period (Figure 3). A one way
ANOVA revealed significant differences between the four
treatment groups in the number of BrdU/NeuN positive cells
GCSF, Learning & Neurogenesis
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increase in newborn cells in the dentate gyrus of trained/G-CSF-
treated animals compared to all other treatment groups. However
the most prominent difference was found between trained/G-
CSF-treated and non-trained/vehicle-treated animals (p,0.001).
G-CSF treatment in combination with the spatial training in the
maze increased the amount of BrdU/NeuN double-positive cells
by 48%. In untrained, G-CSF treated animals there was an
observable increase in BrdU/NeuN positive cells, though not
reaching significance when compared to untrained animals treated
with the vehicle. (p=0.09).
A one way ANOVA revealed significant differences between the
four treatment groups in the total number of BrdU positive cells
(F(3,39): 4.605; p=0.008). Post hoc analyses showed a significant
increase in newborn cells in the dentate gyrus of trained-G-CSF-
treated animals compared to non-trained/vehicle-treated animals
(p,0.001). Furthermore, there was an observable albeit insignif-
icant difference between the trained-G-CSF-treated group and the
trained-vehicle-treated group (p=0.069). In untrained animals, G-
CSF treatment did not result in a statistically significant increase in
BrdU positive cells when compared to vehicle treatment
(p=0.094). To investigate possible neuron-specific effects of G-
CSF treatment we analyzed the percentage of BrdU/NeuN
positive cells in the dentate gyrus. G-CSF treatment exerts no
significant neuron-specific effects (one way ANOVA: p=0.088).
We analyzed the number of BrdU positive cells in the olfactory
bulb, another neurogenic niche of the brain. Neither G-CSF
treatment alone nor in combination with spatial training led to an
increase in the amount of newborn cells in this area (one way
ANOVA: p=0.182; non-trained/vehicle-treated: 56851 cells +/




Our data show that treatment with the hematopoietic factor G-
CSF combined with cognitive training improves long-term spatial
memory and promotes the survival of newborn hippocampal
neurons.
The reduction in reference memory errors during the acquisition
period reflects improved acquisition of spatial memory directly after
G-CSF treatment. At this stage, G-CSF did not increase the number
of newborn neurons measured by DCX-immunohistochemistry.
Newly generated neurons in the adult hippocampus must achieve
full maturation before they become functional and influence
behavior [14]. Therefore, neurogenesis is unlikely to be directly
involved in this immediate learning improvement. Learning
enhancement by G-CSF at this stage may, however, have been
duetoaninteraction ofG-CSFwith itsreceptorinthehippocampus,
resulting in CREB activation via MEK/ERK signaling. G-CSF
activates the MAP kinase pathway by activating ERK 1,2 and 5 [9].
Recent studies have highlighted the importance of ERK in synaptic
plasticity and memory formation across many species, brain areas
and types of synapses [15,16]. CREB is presumed to be a direct
downstream target of activated ERK[17].Thereisevidence that the
activation of CREB in the dorsal hippocampal CA3 region is a
critical step in the signaling cascade that leads to the structural
changes underlying the formation of long-term memory [18,19].
In addition to the enhanced performance during spatial
learning, G-CSF treatment led to a significant improvement in
reference and working memory during reacquisition 26 days later.
Spatial learning is initially dependent on the hippocampus, which
appears to prepare contents for long-term storage in the
neocortex. Newborn neurons in the hippocampus could contribute
to learning and memory formation [20]. Furthermore, neuronal
turnover may provide plasticity for information storage that more
differentiated neurons cannot [21]. Consistent with this idea, the
survival of young adult-born neurons can be increased by learning
and enriched environments [22–25]. In the current study, G-CSF
treatment did not increase the number of DCX-positive newborn
cells immediately following the 11-day treatment and training
period. In contrast, subsequent to the reacquisition, we found an
increase in the number of BrdU/NeuN-positive cells in G-CSF
treated and trained animals. Adult-born neurons may contribute
to cognitive functions if they are functionally integrated in the
hippocampal formation. After labeling newly generated hippo-
campal cells with a retrovirus expressing a reporter gene, van
Praag and colleagues [26] showed that, over a period of weeks,
new cells developed electrophysiological characteristics very
similar to older granule cells. Hence, adult-generated neurons
have the ability to become electrophysiologically functional and
integrate into the hippocampal formation as granule cells.
Figure 2. Spatial reference (a) and working (b) memory-
formation in rats treated with vehicle or G-CSF during the
spatial learning and re-acquisition. G-CSF significantly improved
reference memory during the acquisition (Blocks 1–11; p=0.015;
ANOVA with repeated measures) and re-acquisition (Blocks 37–39;
p=0.004) period. Furthermore, G-CSF improves working memory in the
re-acquisition (p=0.033) but not in the initial acquisition phase
(p=0.952).
doi:10.1371/journal.pone.0005303.g002
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survival of newborn neurons [22,24], others which show no effect
[27] and still others showing learning may decrease the survival of
newborn hippocampal neurons [28]; [29]. Two recently published
studies suggest that the age of the labeled cells at the time of
learning is critical in determining the effects [30,31]. In the current
study, we used DCX and BrdU as markers for neurogenesis at two
time points to evaluate the survival of newborn hippocampal
neurons. DCX is a reliable and specific marker that reflects levels
of adult neurogenesis and its modulation. The expression of DCX
starts as neuroblasts are generated and peaks during the second
week [32]. Therefore, this technique is well suited for the detection
of immediate effects on neurogenesis. For the detection of longer-
term survival of newborn neurons, we injected BrdU on a daily
Figure 3. Quantification of neurogenesis by the detection of BrdU/NeuN-expressing cells. A–C: Confocal microscopic images
immunohistochemically stained cells. A: BrdU positive cells. B: NeuN positive cells. C: merged image, BrdU/NeuN positive cells (arrows). D–F:
Histograms representing the number of (D) BrdU and (F) BrdU/NeuN-expressing cells (mean6S.E.M.) as well as (E) the percentage of BrdU/NeuN
positive cells in the dentate gyrus of vehicle and G-CSF treated rats with and without training in the radial-arm maze after the 3-day re-acquisition
period. * p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0005303.g003
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BrdU/NeuN-labelled cells following the perfusion of the animals
on day 40. In the present study the combination of G-CSF
treatment and cognitive training markedly increased the number
of BrdU/NeuN-positive cells in the hippocampus, clearly
surpassing the survival-enhancing effect of each treatment alone.
G-CSF may promote the surviving of newborn cells trough its
well-investigated anti-apoptotic effects as well as trough its
prominent actions in proliferation and differentiation of neural
cells. The mechanism whereby learning increases cell survival has
not been fully identified yet. A ‘use it or lose it’ principle is thought
to underlie the survival of hippocampal neurons [33]. The finding
of the present study suggests that the combination of hippocam-
pus-dependent learning and G-CSF treatment may facilitate the
integration of adult-born neurons into existing neural networks
and therefore insure their survival.
Numerous reports have described the efficacy of G-CSF in
animal models of different neurological diseases including stroke
[9,34–37], Parkinson’s disease [38,39], and recently Alzheimer’s
disease [40] and amyotrophic lateral sclerosis [41]. Interestingly, in
animal models of stroke and Alzheimer’s disease, treatment with
G-CSF has been shown to ameliorate cognitive deficits [40,42].
Although, recent studies have begun to explore G-CSF-related
mechanisms of action in various disease models, little is known
about its function in the healthy brain. A more detailed
understanding of the physiological role of G-CSF in the healthy
brain may, however, open new insights into disease relevant
mechanisms. We therefore investigated the effect of peripheral
administered G-CSF on learning and memory formation and the
generation and survival of newborn hippocampal neurons in
healthy rats.
Overall, the findings from the present study support the
hypothesis that G-CSF can enhance learning and memory
formation. Most importantly because of its easy applicability and
its history as a well-tolerated hematological drug, learning
enhancement by G-CSF opens up new neurological treatment
opportunities in conditions where learning and memory-formation
deficits occur.
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